SCHEMBL31108872

SCHEMBL31108872

CCOC(=O)C(C)(C)CCCCC(CCCCC(C)(C)C(=O)OCC)OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 3/20 0.60
▸ CYP4A11 Q02928 3/20 0.60
▸ PKM P14618 3/20 0.40
▸ THRB P10828 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ ACACB O00763 1/20 0.39
▸ ACACA Q13085 1/20 0.39
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TBXAS1 P24557 1/20 0.36
▸ MMP8 P22894 1/20 0.35
▸ CPB2 Q96IY4 1/20 0.34
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ ELANE P08246 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ PRKCA P17252 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108835 0.98 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108831 0.98 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108841 0.98 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108832 0.98 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108852 0.88 CYP4F2 (0.58) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108844 0.85 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108879 0.85 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108836 0.85 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108922 0.85 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT
SCHEMBL31108860 0.85 CYP4F2 (0.63) CYP4F2CYP4A11PKMTHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695266-A1 SUBSTITUTED ALKANOIC-DIACIDS COMPOUND AND COMPOSITION AND USE THEREOF Meta Pharmaceuticals (HK) Limited (HK) 2026-02-18 — — EP disclosed
WO-2024213143-A1 SUBSTITUTED ALKANOIC-DIACIDS COMPOUND AND COMPOSITION AND USE THEREOF META PHARMACEUTICALS (HK) LIMITED (CN) 2024-10-17 — — WO disclosed
Send feedback